Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
The legal entity change process brings numerous challenges for stakeholders, particularly when it comes to compliance risks. From a labeling perspective, it is crucial to consider the strategy, timeline, and data transfers necessary to procure and update the labels while accommodating the regulations of the new entity. A failure to properly account for these factors can lead to non compliance internally and with regulatory authorities.
Learn how IQVIA can help your team meet the process specific requirements for each type of labeling activity.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
Change the model of clinical research by integrating data, expertise, analytics and technology from study design through execution to power better decisions.
Improve the performance of your clinical trials with the power of the IQVIA CORE.
Navigate complex regulatory requirements with expert insights and bring transparency, efficiency and predictability to your regulatory affairs strategy.
Meet the challenge of changing stakeholder demands and increasing cost constraints with IQVIA's integrated technology services and analytics-driven offerings.
Automate and standardize your regulatory management, from correspondence and commitments to registration and tracking.
Reimagine regulatory service delivery.